Short contact therapy with tazarotene in psoriasis vulgaris

Stefano Veraldi, Ruggero Caputo, Alessia Pacifico, Ketty Peris, Rosario Soda, Sergio Chimenti

Research output: Contribution to journalArticlepeer-review


Background: We present the results of a multicentre, not controlled, clinical study on the tolerability and efficacy of tazarotene gel, used as short contact therapy (SCT), in psoriasis vulgaris. Objective: To evaluate whether irritant contact dermatitis caused by tazarotene was less frequent and/or less severe with SCT than with traditional therapy, and whether SCT with tazarotene was as effective as traditional therapy. Methods: Forty-three patients with plaque psoriasis were treated by SCT with 0.1% tazarotene gel (once daily application for 20 min, followed by washing with water). Treatment duration was 45 days. Results: Irritant contact dermatitis caused by tazarotene used as SCT was much less frequent and severe than traditional treatment with the same drug. SCT with tazarotene was effective in the treatment of plaque psoriasis. Conclusion: Tazarotene, used as SCT, was better tolerated than the same drug used as traditional treatment. Furthermore, SCT appeared to be as effective as traditional therapy with the same drug.

Original languageEnglish
Pages (from-to)235-237
Number of pages3
Issue number3
Publication statusPublished - Mar 2006


  • Contact dermatitis, irritant
  • Contact therapy, short
  • Psoriasis vulgaris
  • Tazarotene

ASJC Scopus subject areas

  • Dermatology


Dive into the research topics of 'Short contact therapy with tazarotene in psoriasis vulgaris'. Together they form a unique fingerprint.

Cite this